Artiva Biotherapeutics (ARTV) EBITDA (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported EBITDA of -$23.6 million for Q1 2026, down 17.12% year-over-year from -$28.5 million in Q1 2025, and down 13.88% quarter-over-quarter from -$20.8 million in Q4 2025.
Artiva Biotherapeutics (ARTV) EBITDA (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of EBITDA data on file, last reported at -$23.6 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$23.6 million, down 17.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$87.1 million (down 21.08% YoY), and the FY2025 annual result was -$83.6 million, down 27.08% from the prior year.
- EBITDA eased to -$23.6 million in Q1 2026 per ARTV's latest filing, from -$20.8 million in the prior quarter.
- Over five years, EBITDA peaked at $11.4 million in Q3 2023 and troughed at -$23.6 million in Q1 2026.
- A 4-year average of -$15.4 million and a median of -$17.6 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2026: EBITDA slumped 251.05% in 2024, then declined 17.12% in 2026.
- A 4-year view of EBITDA shows it stood at -$12.0 million in 2023, then plunged by 38.47% to -$16.6 million in 2024, then dropped by 25.32% to -$20.8 million in 2025, then dropped by 13.88% to -$23.6 million in 2026.
- Business Quant data shows ARTV's EBITDA at -$23.6 million in Q1 2026, -$20.8 million in Q4 2025, and -$21.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | -23.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.64 Mn |
| Dec 31, 2025 | -20.76 Mn |
| Sep 30, 2025 | -21.44 Mn |
| Jun 30, 2025 | -21.25 Mn |
| Mar 31, 2025 | -20.18 Mn |
| Dec 31, 2024 | -16.56 Mn |
| Sep 30, 2024 | -17.26 Mn |
| Jun 30, 2024 | -17.93 Mn |
| Mar 31, 2024 | -14.06 Mn |
| Dec 31, 2023 | -11.96 Mn |
| Sep 30, 2023 | 11.42 Mn |
| Jun 30, 2023 | -11.16 Mn |